127 related articles for article (PubMed ID: 9744121)
1. A comparison of the prevalence of HIV infection and injecting risk behaviour in urban and rural samples in Scotland.
Haw S; Higgins K
Addiction; 1998 Jun; 93(6):855-63. PubMed ID: 9744121
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
[TBL] [Abstract][Full Text] [Related]
4. Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices.
Peters A; Davies T; Richardson A
Addiction; 1998 Feb; 93(2):253-67. PubMed ID: 9624726
[TBL] [Abstract][Full Text] [Related]
5. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
[TBL] [Abstract][Full Text] [Related]
6. Mobility of Scottish injecting drug users and risk of HIV infection.
Goldberg DJ; Frischer M; Taylor A; Green ST; McKeganey N; Bloor M; Reid D; Cossar J
Eur J Epidemiol; 1994 Aug; 10(4):387-92. PubMed ID: 7843341
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
9. Young and recent-onset injecting drug users are at higher risk for HIV.
Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
[TBL] [Abstract][Full Text] [Related]
10. [Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, I994-2002].
de Boer IM; Op de Coul EL; Beuker RJ; de Zwart O; Al Taqatqa W; van de Laar MJ
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2325-30. PubMed ID: 15587051
[TBL] [Abstract][Full Text] [Related]
11. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
12. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.
Platt L; Rhodes T; Hickman M; Mikhailova L; Lisetsky K; Sarang A; Lewis K; Parry J
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):623-31. PubMed ID: 18209680
[TBL] [Abstract][Full Text] [Related]
13. HIV in injecting drug users in Edinburgh: prevalence and correlates.
Davies AG; Dominy NJ; Peters A; Bath GE; Burns SM; Richardson AM
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):399-405. PubMed ID: 7882106
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia.
Kolarić B; Stajduhar D; Gajnik D; Rukavina T; Wiessing L
Cent Eur J Public Health; 2010 Jun; 18(2):104-9. PubMed ID: 20939261
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
16. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.
McAuley A; Palmateer NE; Goldberg DJ; Trayner KMA; Shepherd SJ; Gunson RN; Metcalfe R; Milosevic C; Taylor A; Munro A; Hutchinson SJ
Lancet HIV; 2019 May; 6(5):e315-e324. PubMed ID: 30981674
[TBL] [Abstract][Full Text] [Related]
17. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus, HIV and human T-cell leukaemia/lymphoma viruses in injecting drug users in Tayside, Scotland, 1993-7.
McIntyre PG; Hill DA; Appleyard K; Taylor A; Hutchinson S; Goldberg DJ
Epidemiol Infect; 2001 Feb; 126(1):97-101. PubMed ID: 11293687
[TBL] [Abstract][Full Text] [Related]
19. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
[TBL] [Abstract][Full Text] [Related]
20. Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India.
Sarkar K; Panda S; Das N; Sarkar S
Indian J Public Health; 1997; 41(2):49-51. PubMed ID: 9988977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
